GLP-1s

The bipartisan opioids bill, awaiting President Donald Trump's signature, would allow hospice workers to destroy a patient's unneeded opioids to reduce the risk of future misuse, according to Kaiser Health News.

The comprehensive opioids bill passed by the Senate and Congress includes a provision to protect opioid use disorder patients from a predatory practice known as patient brokering, according to The Washington Post.

Many patients unable to obtain the anti-addiction drug Suboxone due to strict federal requirements are turning toward illicit means to secure the medication, which helps curb opioid withdrawal symptoms, according to NPR.

Numerous resources and strategies exist for physicians seeking to help patients with opioid use disorder access specialized care, according to AMA Wire.

Evanston, Ill.-based Northshore University HealthSystem's center for personalized medicine rolled out a new test to assess patients' risk of developing prostate cancer.

The National Institutes of Health awarded seven institutions $28.6 million to establish three genome centers as part of the All of Us Research Program.

Richard Sackler, MD, whose family owns Purdue Pharma, earned a patent for a new formulation of buprenorphine, according to STAT.

Purdue Pharma will donate $3.4 million to the nonprofit drug company Harm Reduction Therapeutics to develop a cheaper opioid overdose antidote.

Many companies and scientists are stepping up developmental efforts to make less addictive pain medications amid the ongoing opioid epidemic, according to Science.

A study published in JAMA Surgery examined the types of interventions that are effective for improving stewardship in opioid prescribing postsurgery.